Login to Your Account


'Convergence of great human biology and computational science'

Privately held Hemoshear Therapeutics LLC signaled its intention to compete both with small peers and big biopharma in the race to develop therapies for liver diseases, especially NASH, by luring Takeda Pharmaceutical Co. Ltd. to a funded three-year discovery and development pact.

more »


Our Habitat for All Things Science
Alternate circuit may yield obesity, cachexia targets
Opinion


Partners in Focus